Bixiye
QP20-19 Pharmacy Benefit Exclusion for Ultomiris (ravulizumab-cwvz) IV Injection
Taariikhda uu dhaqangalayo Barnaamijka: Mar 13, 2019
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2771 - 2780 ee natiijooyinka 3289
Bixiye
P21R1-19 Update: Reminder Regarding Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Pre-certification Requirements
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2019
Bixiye
P6R1-19 Update: Delay in Process Change for Requesting Precertification for Skilled Nursing Facility, Long Term Acute Care and Inpatient Rehabilitation Admissions
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2019
Bixiye
P23-19 Prior Authorization Start Date for Urgent and Non-Urgent Preservice Requests
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2019
Bixiye
P27-19 Required Use of Authorization Portal to Submit Preservice Inpatient and Outpatient Prior Authorization and PAN Requests
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2019
Bixiye
P31-19 Medicare Crossover Process Change Effective During Second Quarter 2019
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2019
Bixiye
P30-19 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization, Notification, and Medical Policy Requirements
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2019
Bixiye
2019 March Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2019
Bixiye
P26-19 New Medical, Medical Drug and Behavioral Health Policy Management Updates for Commercial & Medicare Advantage Lines of Business – Effective May 6, 2019
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2019
Bixiye
P28-19 Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Members – eviCore Healthcare Utilization Management Program
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2019